Increasing Equity in Lung Cancer Screening | MicrobiomeTrials← Back to trialsNCT06360822
Increasing Equity in Lung Cancer Screening
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2023-12-01Est. Completion: 2027-06-01
Enrollment target: 144 participants Locations- Eskenazi Health, Indianapolis, Indiana, United States
Other microbiome trials you might be interested in
Respiratory Recurrent Papillomatosis (RRP)Human Papillomavirus (HPV)Papillomavirus InfectionLaryngeal DiseasesTracheal DiseasesRespiratory Tract Neoplasm
Background:
Recurrent respiratory papillomatosis (RRP) is a rare disease that causes wart-like growths called papilloma…
Bethesda, United StatesEst. completion Jul 1, 2029
Non Squamous Non Small Cell Lung Cancer
This is a randomized, multicenter, multinational, double-blind, integrated pharmacokinetics (PK) and efficacy similarity…
Yerevan, ArmeniaEst. completion Aug 31, 2026
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
This phase II trial tests how well biologically guided radiation therapy (BgRT) and stereotactic body radiation therapy …
Duarte, United StatesCompleted Mar 9, 2027